A randomized open label trial of tenofovir monotherapy versus tenofovir plus telbivudine in spontaneous reactivation of hepatitis B

BACKGROUND/AIM: Acute-on-chronic liver failure (ACLF-B) in spontaneous reactivation of chronic hepatitis B (SR-CHB) has high mortality. Tenofovir disoproxil fumarate (TDF) improves survival by ~40% in ACLF-B but is potentially nephrotoxic. Combining telbivudine (LDT) with TDF may negate this risk an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Saudi J Gastroenterol
Main Authors: Jindal, Ankur, Vyas, Ashish, Sharma, Manoj, Kumar, Guresh, Sarin, Shiv K.
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer - Medknow 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6784432/
https://ncbi.nlm.nih.gov/pubmed/31044748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/sjg.SJG_537_18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados